"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,A,US 5190929 A,113-691-845-729-833,1993-03-02,1993,US 19840688 A,1988-05-25,US 19840688 A,1988-05-25,CYCLOPHOSPHAMIDE ANALOGS USEFUL AS ANTI-TUMOR AGENTS,"Cyclophosphamides possessing anti-tumor activity and having the formula ##STR1## and salts thereof; wherein R is lower alkyl, aryl, aryl-lower alkyl or a nitrogen, sulfur or oxygen containing heterocyclic or heterocyclic lower alkyl, and R' is hydrogen, hydroxy or OOH with the proviso that when R' is hydrogen, R is other than methyl or phenyl and when R' is hydroxy, R is other than methyl.",RES CORP TECHNOLOGIES INC,BORCH RICHARD F;;CANUTE GREGORY W,RESEARCH CORPORATION TECHNOLOGIES INC. A CORP. OF DE (1988-08-17),https://lens.org/113-691-845-729-833,Granted Patent,yes,2,35,2,2,0,C07F9/65846;;C07F9/65846,C07F9/6584,514/80;;514/82;;514/85;;514/86;;514/89;;514/91;;514/92;;514/94;;514/95;;514/96;;514/99;;514/100;;514/110;;544/232;;546/22;;546/23;;548/112;;548/113;;548/413;;548/414;;549/6;;549/218;;549/220,25,19,066-998-279-929-884;;000-102-202-919-355;;003-460-270-771-443;;061-227-781-138-60X;;077-592-655-457-833;;052-199-318-085-698;;032-453-626-068-14X;;169-906-247-868-216;;013-522-390-638-78X;;053-684-441-486-644;;023-365-965-782-907;;043-506-058-745-696;;024-614-222-374-348;;091-014-622-245-909;;102-176-576-465-239;;005-693-924-103-074;;003-460-270-771-443;;108-681-587-734-831;;011-718-374-189-015,10.1016/0009-2797(77)90140-5;;890840;;10.1016/0006-2952(75)90180-x;;1125063;;3737628;;10.3987/r-1986-06-1599;;10.1016/0091-3057(86)90492-2;;641817;;10.1002/jps.2600670539;;3664493;;1277209;;155503;;10.1007/bf00253142;;6842507;;10.1021/jm00359a011;;7310816;;10.1021/jm00144a006;;10.1021/jm00200a013;;621716;;7298626;;10.1016/s0021-9258(19)68462-0;;10.1021/jm00178a005;;7381836;;3743371;;3701785;;10.1021/jm00155a022;;13684379;;10.3987/r-1978-09-1277;;3737628;;10.3987/r-1986-06-1599;;10.1016/0091-3057(86)90492-2;;10.3987/r-1984-12-2799;;10.1021/jm00188a006;;423194,"Pazdur, Proc. Am. Soc. Clin. Oncology 3, p. 219 (1984).;;Martin et al, Cancer Research 49, 2189 (1986).;;Farmer, Chem Biol. Interactions 18, 47 57 (1977).;;Cox, I Adv. Mass Spectrum. Biochem & Medicine, 1, 59 71 (1976).;;Cox II Biochem. Pharmacol 24 p. 599 (1975).;;Shih, Heterocycles 24(6) 1599 603 (1986).;;Cyclophosphamide, Merck Index, p. 2736.;;Foster, Journal of Pharmaceutical Sciences, 67, 709 710 (1978).;;Sakuri, Cancer Chemother. Cent., Japan Found. Cancer Res. 272 281 (1978).;;Arndt, et al., Cancer Research, 47, 5932 5934 (1987).;;Friedman, et al., Cancer Treatment Reports, 60, 337 345 (1976).;;Carter, Cancer Chemother Pharmacol, 1, 15 24 (1978).;;Camerman, et al., J. Med. Chem., 26, 679 683 (1983).;;Foster, et al., J. Med. Chem., 24, 1399 1403 (1981).;;Takamizawa, et al., Journal of Medicinal Chemistry, 21, 208 214 (1978).;;White, et al., JACS, 101, 1937 1942 (1978).;;Gurtoo, et al., Journal of Biological Chemistry, 256, 11691 11701 (1976).;;Boyd, et al., J. Med. Chem., 23, 372 375 (1980).;;Ludeman, et al., Drugs, Exp. Clin. Res., XII, 527 532 (1986).;;Ludeman, et al., J. Med. Chem., 29, 716 727 (1980).;;Arnold, et al., Arzneim, Forsch., 11, 143 (1961).;;Shih, et al., Heterocycles, 9, 1277 (1978).;;Shih, et al., Heterocycles, 24, 1599 (1986).;;Shih, et al., Heterocycles, 22, 2799 (1984).;;Ludeman et al, J. Med. Chem. , vol. 22, No. 2, (1979), pp. 151 158.",EXPIRED
2,WO,A1,WO 1989/011278 A1,162-727-305-911-772,1989-11-30,1989,US 8902238 W,1989-05-23,US 19840688 A,1988-05-25,CYCLOPHOSPHAMIDE ANALOGS USEFUL AS ANTI-TUMOR AGENTS,"Cyclophosphamides possessing anti-tumor activity and having formula (I) and salts thereof; wherein R is lower alkyl, aryl, aryl-lower alkyl or a nitrogen, sulfur or oxygen containing heterocyclic or heterocyclic lower alkyl, and R' is hydrogen, hydroxy or OOH with the proviso that when R' is hydrogen, R is other than methyl or phenyl and when R' is hydroxy, R is other than methyl.",RES CORP TECHNOLOGIES INC,BORCH RICHARD F;;CANUTE GREGORY W,,https://lens.org/162-727-305-911-772,Patent Application,yes,1,0,2,2,0,C07F9/65846;;C07F9/65846,C07F9/6584,,0,0,,,,PENDING
3,EP,A1,EP 0418292 A1,146-696-325-402-423,1991-03-27,1991,EP 89906634 A,1989-05-25,US 19840888 A,1988-05-25,PHOSPHORAMIDES USEFUL AS ANTITUMOR AGENTS.,"Composé antitumoral de la formule (I), dans laquelle R1 et R2 peuvent être identiques ou différents et sont choisis dans le groupe composé d'hydrogène ou d'alkyle inférieur lequel est mono-substitué par halo, hydroxy ou alkoxy inférieur à condition que le substituant ne soit pas dans le -carbone; ou R1 et R2 pris ensemble avec l'azote auquel ils sont liés forment un anneau morpholian. R représente un aryle à substitution nitro ou un azote à substitution nitro, des groupes hétéroaromatiques contenant du sufre ou de l'oxygène. R3 et R4 représentent chacun indépendament de l'hydrogène, un groupe de retrait d'électrons ou de l'akyle inférieur non substitué ou mono substitué par de l'alkyle ou un groupe de retrait d'électrons.",RES CORP TECHNOLOGIES INC,BORCH RICHARD F;;CANUTE GREGORY W;;VALENTE RONALD R,"RESEARCH CORPORATION TECHNOLOGIES, INC. (1994-02-09)",https://lens.org/146-696-325-402-423,Patent Application,yes,0,0,4,5,0,A61P35/00;;C07F9/2458;;C07F9/2429;;C07F9/6506,A61K31/685;;A61P35/00;;C07F9/24;;C07F9/572;;C07F9/58;;C07F9/6506;;C07F9/6533,,0,0,,,,DISCONTINUED
4,US,A,US 5403932 A,008-477-366-513-468,1995-04-04,1995,US 26004094 A,1994-06-15,US 26004094 A;;US 74193091 A;;US 19840888 A,1988-05-25,Phosphoramidates useful as antitumor agents,"Compounds of the formula: ##STR1## which is further defined herein, possess anti-tumor activity.",RES CORP TECHNOLOGIES INC,BORCH RICHARD F;;CANUTE GREGORY W;;VALENTE RONALD R,,https://lens.org/008-477-366-513-468,Granted Patent,yes,2,14,1,5,0,C07F9/2429;;C07F9/2458;;C07F9/6506;;C07F9/2458;;C07F9/2429;;C07F9/6506,C07F9/24;;C07F9/6506,546/22;;544/124;;544/128;;544/146;;544/157;;546/23;;548/119;;558/169;;558/179;;558/191;;549/6,7,5,024-614-222-374-348;;091-014-622-245-909;;013-522-390-638-78X;;053-684-441-486-644;;052-199-318-085-698,3743371;;3701785;;10.1021/jm00155a022;;7310816;;10.1021/jm00144a006;;10.1021/jm00200a013;;621716;;1277209,"Carter, S. K. et al. Chemotherapy of Cancer; Second Edition; John Wiley and Sons: New York, 1981; Appendix C.;;Chemical Abstracts 1990, 112(21), 198797n; PCT Int. Appl. WO 89 11,484, publ. Nov. 30, 1989.;;Ludeman, et al., Drugs Expt. Clin. Res. XII, 527 532 (1986).;;Ludeman, et al., J. Med. Chem., 29, 716 727 (1986).;;Foster, et al., J. Med. Chem., 24, 1399 1403 (1981).;;Takamizawa, et al., Journal of Medicinal Chemistry, 21, 208 214 (1978).;;Friedman, et al., Cancer Treatment Reports, 60, 337 346 (1976).",EXPIRED
5,WO,A1,WO 1989/011484 A1,038-772-946-617-036,1989-11-30,1989,US 8902299 W,1989-05-25,US 19840888 A,1988-05-25,PHOSPHORAMIDES USEFUL AS ANTITUMOR AGENTS,"An antitumor compound of formula (I), wherein R1 and R2 may be the same or different and are selected from the group consisting of hydrogen or lower alkyl which is non-substituted with halo, hydroxy or lower alkoxy, provided that the substituent is not on the -carbon; or R1 and R2 taken together with the nitrogen to which they are attached form a morpholion ring. R is a nitro-substituted aryl or nitro-substituted nitrogen, sulfur or oxygen containing heteroaromatic groups R3 and R4 are each independently hydrogen, an electron withdrawing group or lower alkyl which is unsubstituted or mono-substituted with alkyl or an electron withdrawing group.",RES CORP TECHNOLOGIES INC,BORCH RICHARD F;;CANUTE GREGORY W;;VALENTE RONALD R,,https://lens.org/038-772-946-617-036,Patent Application,yes,1,11,4,5,0,A61P35/00;;C07F9/2458;;C07F9/2429;;C07F9/6506,A61K31/685;;A61P35/00;;C07F9/24;;C07F9/572;;C07F9/58;;C07F9/6506;;C07F9/6533,,1,0,,,See also references of EP 0418292A4,PENDING
6,EP,A4,EP 0418292 A4,103-507-611-837-027,1991-09-25,1991,EP 89906634 A,1989-05-25,US 19840888 A,1988-05-25,PHOSPHORAMIDES USEFUL AS ANTITUMOR AGENTS,,"RESEARCH CORPORATION TECHNOLOGIES, INC","BORCH, RICHARD, F.;;CANUTE, GREGORY, W.;;VALENTE, RONALD, R.","RESEARCH CORPORATION TECHNOLOGIES, INC. (1994-02-09)",https://lens.org/103-507-611-837-027,Search Report,no,1,0,4,5,0,A61P35/00;;C07F9/2458;;C07F9/2429;;C07F9/6506,A61K31/685;;A61P35/00;;C07F9/24;;C07F9/572;;C07F9/58;;C07F9/6506;;C07F9/6533,,1,0,,,See also references of WO 8911484A1,DISCONTINUED
